Published on
May 18, 2020
- 19:01 GMT
Spectral Analytics to Launch Patient Trial for COVID-19 Treatment
NEW YORK, NY, UNITED STATES, May 18, 2020 /EINPresswire.com/ -- New York-based biotech company, Spectral Analytics (“Spectral”), which is working with the FDA to seek approval to initiate patient trials for a potential treatment for COVID-19. The …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
